The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2E,6E)-3,7-dimethyltrideca-2,6-dien-1-yl diphosphate ID: ALA3818422
PubChem CID: 127049367
Max Phase: Preclinical
Molecular Formula: C15H30O7P2
Molecular Weight: 384.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCC/C(C)=C/CC/C(C)=C/COP(=O)(O)OP(=O)(O)O
Standard InChI: InChI=1S/C15H30O7P2/c1-4-5-6-7-9-14(2)10-8-11-15(3)12-13-21-24(19,20)22-23(16,17)18/h10,12H,4-9,11,13H2,1-3H3,(H,19,20)(H2,16,17,18)/b14-10+,15-12+
Standard InChI Key: IYHFEEQPTBFYNK-VDQVFBMKSA-N
Molfile:
RDKit 2D
24 23 0 0 0 0 0 0 0 0999 V2000
14.2999 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5999 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9999 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6999 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9999 -1.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3999 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0999 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7999 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5000 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2000 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9000 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6000 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3000 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2606 0.1503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8999 0.7500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.1999 0.0000 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
19.4998 0.7500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1607 -0.6002 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.1999 -1.2000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.7998 0.0000 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
21.8390 -0.6002 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.8393 0.5997 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.7998 -1.2000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7999 -1.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
3 4 1 0
3 5 1 0
4 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
2 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
16 19 1 0
17 20 1 0
20 21 1 0
20 22 2 0
20 23 1 0
8 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 384.35Molecular Weight (Monoisotopic): 384.1467AlogP: 4.86#Rotatable Bonds: 13Polar Surface Area: 113.29Molecular Species: ACIDHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 1.77CX Basic pKa: ┄CX LogP: 4.18CX LogD: -0.85Aromatic Rings: ┄Heavy Atoms: 24QED Weighted: 0.24Np Likeness Score: 1.79
References 1. Temple KJ, Wright EN, Fierke CA, Gibbs RA.. (2016) Exploration of GGTase-I substrate requirements. Part 2: Synthesis and biochemical analysis of novel saturated geranylgeranyl diphosphate analogs., 26 (15): [PMID:27342751 ] [10.1016/j.bmcl.2016.06.035 ]